Investment Thesis
Tenon Medical is an early-stage surgical device company with promising 20.4% revenue growth and healthy 59.8% gross margins, indicating product-market fit. However, the company is burning $10.7M annually in operating cash flow against only $3.9M in revenue, with approximately 4 months of cash runway at current burn rates. Without rapid revenue acceleration, significant cost reduction, or emergency financing, the company faces severe solvency risk.
Strengths
- Strong gross margin of 59.8% indicates strong product value and pricing power
- Revenue growing 20.4% YoY demonstrates market demand for surgical devices
- Debt-free balance sheet with no long-term debt obligations
- Adequate short-term liquidity with 2.11x current ratio and 1.78x quick ratio
- Net loss improving 8.2% YoY shows operational efficiency gains
Risks
- Severe cash burn of $10.7M annually against $3.9M revenue creates ~4 month runway with current $3.8M cash reserves
- Operating margin of -324.3% indicates operating expenses 13x revenue, unsustainable even for early-stage companies
- Free cash flow of -$11.0M compounds liquidity crisis and limits ability to fund operations without external capital
- Negative ROE (-249.1%) and ROA (-116.7%) indicate extremely poor capital efficiency and asset utilization
- High dilution risk from required future financing at distressed valuations
Key Metrics to Watch
- Quarterly revenue trajectory and acceleration toward gross profit breakeven
- Operating cash burn rate and monthly cash consumption trends
- Gross margin sustainability as volume scales
- Cash balance depletion timeline and financing announcements
- Operating expense reduction or revenue inflection required for survival
Financial Metrics
Revenue
3.9M
Net Income
-12.6M
EPS (Diluted)
$-1.70
Free Cash Flow
-11.0M
Total Assets
10.8M
Cash
3.8M
Profitability Ratios
Gross Margin
59.8%
Operating Margin
-324.3%
Net Margin
-318.4%
ROE
-249.1%
ROA
-116.7%
FCF Margin
-279.4%
Balance Sheet & Liquidity
Current Ratio
2.11x
Quick Ratio
1.78x
Debt/Equity
0.00x
Debt/Assets
53.2%
Interest Coverage
-376.24x
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-04-17T15:51:23.173578 |
Data as of: 2025-12-31 |
Powered by Claude AI